Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 51

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 51
---
 n        |     | No redundancy between short- and long-term incentive plan performance measures.                                                                                                                                                                                                                                                                                                         |     |                                                                                                                                                                                                                                                                                                                         |
| n        |     | No hedging or pledging of The Cigna Group stock by any directors, executive officers, or employees.                                                                                                                                                                                                                                                                                     |     |                                                                                                                                                                                                                                                                                                                         |
| n        |     | No discounting, reloading, or repricing of stock options without shareholder approval.                                                                                                                                                                                                                                                                                                  |     |                                                                                                                                                                                                                                                                                                                         |
| n        |     | No payment of dividends on restricted stock prior to vesting. Unvested SPS awards do not accrue dividends or count towards share ownership guidelines.                                                                                                                                                                                                                                  |     |                                                                                                                                                                                                                                                                                                                         |

Shareholder Support of Our Executive Compensation Program

The Committee and the Board consider the results of the annual shareholder executive compensation “say-on-pay” vote in determining the ongoing design and administration of the Company’s executive compensation programs. Approximately 83% of votes cast at our 2024 annual meeting of shareholders were in favor of the advisory vote on executive compensation, reflecting continued strong support for our executive compensation programs and practices.

The Committee also values and considers feedback on our executive compensation program received as part of our ongoing communications with shareholders. Since the filing of our 2024 proxy statement, we invited holders of 70% of our outstanding stock, which included our 100 largest holders, to engage with us on a variety of topics, including executive compensation. During these calls, which, in some cases, included members of our Board of Directors, we

| 56 |     | The Cigna Group| 2025 Notice of Annual Meeting of Shareholders and Proxy Statement |

| COMPENSATION MATTERS |

discussed a number of topics related to our executive compensation programs, including: (1) the elimination of funding ranges in determining the funding factor for each performance measure in the EIP in favor of a formulaic approach; (2) steps taken to formalize the limitations on the Committee’s discretion to fund the EIP and the Committee’s limited use of discretion in determining individual awards; (3) disclosure enhancements, including related to EIP performance measures, goals, and funding percentages; and (4) executive compensation plan design, including performance measures in our EIP and SPS programs and equity allocation and vesting. Additional information regarding our 2024 engagement and shareholder engagement program is included in “Corporate Governance Matters – Shareholder Engagement.”

Processes and Procedures for Determining Executive Compensation

People Resources Committee Oversight of Executive Compensation